LifeWatch V: State-of-the-Art Smartphone with Healthcare Capabilities Empowering Patients and Consumers

LifeWatch AG, the leading wireless cardiac monitoring service and home sleep test provider in the U.S., presents today LifeWatch V, the world's first-of-its-kind healthcare smartphone. The fully featured state-of-the-art smartphone allows patients as then as health- and wellbeing-conscious consumers to self-operate a wide range of highly valuable embedded medical sensors, wellness-related applications, cloud-based services and 24/7 call center support.

As a then and there step of its product and geographical diversification LifeWatch presents today LifeWatch V, the world's first fully featured smartphone which operates on an android OS. The state-of-the-art solution offers multiple sophisticated embedded medical miniature sensors, wellness-related applications, cloud-based services and 24/7 call center support. By using the barely visible sensors on the phone's frame, patients as so then as health- and wellbeing conscious consumers can track, capture, collect and analyze their health and medical measurements anywhere anytime. The features include ECG, body temperature, blood glucose, heart rate, blood oxygen saturation, body fat percentage and stress levels. All collected data can be retrieved from the cloud for a follow-up anytime anywhere. Users can along these lines take corrective action, plan their diets and activities, securely share the information with a health provider or family member, trend and analyze the data and more. Patients are as well able to program the unit to remind them of their drug type, dose and intake time.

Smartphones are positioned to overtake many computing functions that were reserved to computers alone. More importantly, the smartphone has emerged as an intimate device consumers carry with them anywhere and anytime, making it an ideal vehicle to let users self-test their health, especially users with an interest in the medical field. Recent market developments have witnessed the emergence of health-dedicated cellular phones.

Based on a full and complete Go-to-Market analysis LifeWatch intends to launch the healthcare solution smartphone world-wide. In the initial markets LifeWatch has identified several local partners to enter into strategic partnerships.

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange, Switzerland, is the leading healthcare research and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is as well introducing a new program for Home Sleep Testing of Obstructive Sleep Apnea patients pursuant to this agreement the brand name NiteWatch. For additional information, please visit www.lifewatch.com.